Intrinsiqs

Is GSK plc overvalued?

GSK plc (GSK) looks undervalued — trading about 23% below its fair value.

Undervalued
Current price $53.66 Fair value $65.75
Price
$53.66
Fair value
$65.75
Current P/E
12.3
Normal P/E
15.1
Market cap
$107.47B
Dividend yield
3.5%
Return on equity
34.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares GSK's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 4 Jul 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group IncorporatedRHHBY Roche Holding AGMRK Merck & Co., Inc.